Related Experiment Video
Updated: Aug 10, 2026
Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry
Published on: January 7, 2014
High-grade glioma: can we teach an old dogma new tricks?
1Department of Developmental Neurobiology, St. Jude Children's Research Hospital, 332 North Lauderdale Street, Memphis, Tennessee 38105, USA. richard.gilbertson@stjude.org
Insights
High-grade glioma (HGG) remains largely incurable. A new gene expression study offers insights into HGG origins and potential new therapeutic targets for this aggressive brain cancer.
Area of Science:
- Neuro-oncology
- Cancer genomics
- Molecular biology
Background:
- High-grade glioma (HGG) presents a significant clinical challenge due to its poor prognosis and limited treatment options.
- Despite advances in understanding genetic alterations, effective therapies for HGG are lacking.
- This study investigates gene expression profiles in a large HGG cohort.
Discussion:
- The research explores the molecular heterogeneity of high-grade glioma.
- Analysis of gene expression patterns aims to uncover novel biological insights.
- Findings may illuminate the underlying mechanisms driving HGG development and progression.
Key Insights:
- Phillips et al. present extensive gene expression data from a substantial cohort of high-grade glioma patients.
- The study identifies potential new therapeutic targets by analyzing molecular profiles.
- New clues regarding the origins of high-grade glioma are provided.
Outlook:
- This research opens avenues for developing targeted therapies for high-grade glioma.
- Further investigation into identified gene expression patterns could refine HGG classification.
- The findings hold promise for improving patient outcomes in neuro-oncology.
Abstract:
The best efforts of clinicians and biologists battling high-grade glioma (HGG) have been overshadowed by two cruel facts: these tumors are essentially incurable and will kill most patients within months, and emergent knowledge of the genetic alterations in HGG has done nothing to ease this burden of suffering. In this issue of Cancer Cell, Phillips et al. report an extensive study of the gene expression profiles of a large cohort of HGG. Their data provide new clues to the origins of this disease and suggest potential targets for novel therapies.
